Child's Nervous System

, Volume 33, Issue 11, pp 2003–2010 | Cite as

Superselective transvenous embolization with Onyx and n-BCA for vein of Galen aneurysmal malformations with restricted transarterial access: safety, efficacy, and technical aspects

  • Kirill Orlov
  • Anton Gorbatykh
  • Vadim Berestov
  • Timur Shayakhmetov
  • Dmitry Kislitsin
  • Pavel Seleznev
  • Nikolay Strelnikov
Original Paper


Purpose and methods

Superselective transvenous embolization (TVE) with liquid embolic agents is a new concept in treatment of vein of Galen aneurysmal malformations (VGAM). We performed ten sessions of TVE in VGAM patients with restricted transarterial access. In this paper, we assessed clinical and angiographic outcomes of the proposed treatment and discussed three different TVE techniques with regard to morphology of the shunt and outflow tract. Safety and avoidance-of-complication tips were also discussed.


Patient age ranged from 4 to 51 months. There were eight patients with choroidal VGAMs, seven of them were successfully treated with Onyx, and in one case, transvenous catheterization failed. In three cases, adjunctive coiling of draining vein was performed. In three cases, normal deep cerebral veins were connected to the outflow part of malformation; they were preserved during embolization in all cases. Six-month follow-up angiography demonstrated angiographic cure in six cases, and partial occlusion in one.

There were two patients with mural VGAMs: both were treated with n-BCA. Partial occlusion was achieved in both cases.

There was no procedure-related permanent morbidity or mortality. Oculomotor deficit due to quadrigeminal ischemia occurred in one case, and resolved completely after 3 weeks.


TVE with liquid embolic agents is a safe and effective salvage method for VGAMs with restricted transarterial access, previously considered as poor candidates for endovascular treatment.


Vein of Galen malformation Endovascular embolization Transvenous Onyx 


Compliance with ethical standards

After approval by an institutional review board, clinical records and cross-sectional and angiographic data of those patients were retrospectively evaluated.

Conflict of interest

Dr. Orlov is a proctor and consultant for Medtronic in Russian Federation and Commonwealth of Independent States. Other authors have no conflict of interest to declare.


  1. 1.
    Recinos PF, Rahmathulla G, Pearl M, Recinos VR, Jallo GI, Gailloud P, Ahn ES (2012) Vein of Galen malformations: epidemiology, clinical presentations, management. Neurosurg Clin N Am 23(1):165–177CrossRefPubMedGoogle Scholar
  2. 2.
    Lasjaunias PL, Chng SM, Sachet M, Alvarez H, Rodesch G, Garcia-Monaco R (2006) The management of vein of Galen aneurysmal malformations. Neurosurgery 59(5 Suppl 3):S184–S194 discussion S3-13PubMedGoogle Scholar
  3. 3.
    Yan J, Wen J, Gopaul R, Zhang CY, Xiao SW (2015) Outcome and complications of endovascular embolization for vein of Galen malformations: a systematic review and meta-analysis. J Neurosurg 123(4):872–890CrossRefPubMedGoogle Scholar
  4. 4.
    Khullar D, Andeejani AM, Bulsara KR (2010) Evolution of treatment options for vein of Galen malformations. J Neurosurg Pediatr 6(5):444–451CrossRefPubMedGoogle Scholar
  5. 5.
    Meila D, Hannak R, Feldkamp A, Schlunz-Hendann M, Mangold A, Jacobs C, Papke K, Brassel F (2012) Vein of Galen aneurysmal malformation: combined transvenous and transarterial method using a “kissing microcatheter technique”. Neuroradiology 54(1):51–59CrossRefPubMedGoogle Scholar
  6. 6.
    Dowd CF, Halbach VV, Barnwell SL, Higashida RT, Edwards MS, Hieshima GB (1990) Transfemoral venous embolization of vein of Galen malformations. AJNR Am J Neuroradiol 11(4):643–648PubMedGoogle Scholar
  7. 7.
    Albuquerque FC, Ducruet AF, Crowley RW, Bristol RE, Ahmed A, McDougall CG (2014) Transvenous to arterial Onyx embolization. J Neurointerv Surg 6(4):281–285CrossRefPubMedGoogle Scholar
  8. 8.
    Agarwal H, Sebastian LJ, Gaikwad SB, Garg A, Mishra NK (2017) Vein of Galen aneurysmal malformation-clinical and angiographic spectrum with management perspective: an institutional experience. J Neurointerv Surg 9(2):159–164CrossRefPubMedGoogle Scholar
  9. 9.
    Jagadeesan BD, Zacharatos H, Nascene DR, Grande AW, Guillaume DJ, Tummala RP (2016) Endovascular management of a vein of Galen aneurysmal malformation in an infant with challenging femoral arterial access. J Neurosurg Pediatr 18(2):231–234CrossRefPubMedGoogle Scholar
  10. 10.
    Alvarez H, Garcia Monaco R, Rodesch G, Sachet M, Krings T, Lasjaunias P (2007) Vein of Galen aneurysmal malformations. Neuroimaging Clin N Am 17(2):189–206CrossRefPubMedGoogle Scholar
  11. 11.
    Moon JH, Cho WS, Kang HS, Kim JE, Lee SJ, Han MH (2011) Vein of Galen aneurysmal malformation: endovascular management of 6 cases in a single institute. J Korean Neurosurg Soc 50(3):191–194CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Mendes GA, Iosif C, Silveira EP, Waihrich E, Saleme S, Mounayer C (2016) Transvenous embolization in pediatric plexiform arteriovenous malformations. Neurosurgery 78(3):458–465CrossRefPubMedGoogle Scholar
  13. 13.
    Crowley RW, Ducruet AF, Kalani MY, Kim LJ, Albuquerque FC, McDougall CG (2015) Neurological morbidity and mortality associated with the endovascular treatment of cerebral arteriovenous malformations before and during the Onyx era. J Neurosurg 122(6):1492–1497CrossRefPubMedGoogle Scholar
  14. 14.
    Gross BA, Albuquerque FC, Moon K, McDougall CG (2016) Evolution of treatment and a detailed analysis of occlusion, recurrence, and clinical outcomes in an endovascular library of 260 dural arteriovenous fistulas. J Neurosurg 2:1–10Google Scholar
  15. 15.
    Elsenousi A, Aletich VA, Alaraj A (2016) Neurological outcomes and cure rates of embolization of brain arteriovenous malformations with n-butyl cyanoacrylate or Onyx: a meta-analysis. J Neurointerv Surg 8(3):265–272CrossRefPubMedGoogle Scholar
  16. 16.
    Casasco A, Lylyk P, Hodes JE, Kohan G, Aymard A, Merland JJ (1991) Percutaneous transvenous catheterization and embolization of vein of Galen aneurysms. Neurosurgery 28:260–266CrossRefPubMedGoogle Scholar
  17. 17.
    Lylyk P, Viñuela F, Dion JE, Duckwiler G, Guglielmi G, Peacock W, Martin N (1993) Therapeutic alternatives for vein of Galen vascular malformations. J Neurosurg 3:438–445CrossRefGoogle Scholar
  18. 18.
    Levrier O, Gailloud PH, Souei M, Manera L, Brunel H, Raybaud C (2004) Normal galenic drainage of the deep cerebral venous system in two cases of vein of Galen aneurysmal malformation. Childs Nerv Syst 20(2):91–97CrossRefPubMedGoogle Scholar
  19. 19.
    Rangel-Castilla L, Spetzler RF, Nakaji P (2015) Normal perfusion pressure breakthrough theory: a reappraisal after 35 years. Neurosurg Rev 38(3):399–404 discussion 404-5CrossRefPubMedGoogle Scholar
  20. 20.
    Jankowitz BT, Vora N, Jovin T, Horowitz M (2008) Treatment of pediatric intracranial vascular malformations using Onyx-18. J Neurosurg Pediatr 2(3):171–176CrossRefPubMedGoogle Scholar
  21. 21.
    Elijovich L, Choudhri AF, Arthur AS, Klimo P, Boop FA, Berenstein A (2016) Retreatment of a choroidal vein of Galen malformation with embolization 42 years after open surgical treatment in the neonatal period. BMJ Case Rep 4:2016Google Scholar

Copyright information

© Springer-Verlag GmbH Germany 2017

Authors and Affiliations

  1. 1.Division of Interventional Neuroradiology and NeurosurgeryE.N. Meshalkin Siberian Federal Biomedical Research CenterNovosibirskRussia

Personalised recommendations